Further, radiotherapy has been shown to potentiate the anti-tumour effect of CTLA-4 blockade in a CD8 T cell-dependent manner in the aggressive and poorly immunogenic breast cancer model 4T1 (31, 33, 106, 107). This evidence concerns the gene CD8A and breast carcinoma.